Your browser doesn't support javascript.
loading
Completion rates and myelosuppression degrees of cancer patients receiving radiotherapy or chemoradiotherapy unchanged regardless of delay duration after Omicron infection.
Zhang, Zhenyu; Zhou, Juan; Peng, Xun; Li, Ping; Meng, Xue; Hu, Man; Zhao, Miaoqing; Lin, Qinghai; Ru, Kun.
Affiliation
  • Zhang Z; Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Zhou J; Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Peng X; Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Li P; Department of Hematology and Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Meng X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Hu M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
  • Zhao M; Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Lin Q; Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China. linqinghai1988@126.com.
  • Ru K; Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China. kunru@yahoo.com.
Sci Rep ; 14(1): 14226, 2024 06 20.
Article de En | MEDLINE | ID: mdl-38902401
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chimioradiothérapie / SARS-CoV-2 / COVID-19 / Tumeurs Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Sci Rep Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chimioradiothérapie / SARS-CoV-2 / COVID-19 / Tumeurs Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Sci Rep Année: 2024 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni